This suggests that ferroptosis, in conjunction with pyroptosis ( via NLRP3), may regulate atherosclerosis progression, offering insights into potential therapeutic targets for CAD ( 4.1.4 Non-coding RNAs as biomarkers for ferroptosis in CAD Beyond protein-based biomarkers, non-coding RNAs have emerged as ferroptosis biomarkers relevant to CAD
Concurrently, BRAF suppresses oxidative metabolism through distinct mechanisms
CuomoRVandaelePCoulieBPeetersTDepoortereIJanssensJet al
Julianna Lindsey (10:35.673) Thats a great question
Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target
Its level decreases with age (especially from the age of 45-50) and as the body's defence needs increase (immunity, liver detoxification, antioxidant defences...)